Open AccessClinical Outcomes of Patients With Bacteremia Due to Extended-Spectrum β-Lactamase (ESBL)-Producing Enterobacteriaceae (EB) Treated With Carbapenem (Cbp), Standard Intermittent Piperacillin-Tazobactam (SI-PTZ) or Extended Infusion Piperacillin-Tazobactam (EI-PTZ)
Author(s) -
Navaneeth Narayanan,
Tanaya Bhowmick,
Randy W. Jackson,
John Lough,
Melvin P. Weinstein
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.1381
Subject(s) - piperacillin/tazobactam , piperacillin , medicine , bacteremia , tazobactam , carbapenem , enterobacteriaceae , antibiotics , anesthesia , intensive care medicine , microbiology and biotechnology , bacteria , pseudomonas aeruginosa , escherichia coli , biochemistry , chemistry , genetics , gene , biology